Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis-Reference-Cited by-同舟云学术

Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis

Published:2015-02 Issue:2 Volume:49 Page:137-144
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Dasarathy Srinivasan,Dasarathy Jaividhya,Khiyami Amer,Yerian Lisa,Hawkins Carol,Sargent Ruth,McCullough Arthur J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference57 articles.

1. . Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.;Browning;Hepatology,2004

2. . Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.;Flegal;JAMA,2012

3. . Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.;Loomba;Hepatology,2012

4. . Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.;Younossi;Clin Gastroenterol Hepatol,2011

5. The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.;Pagadala;Clin Liver Dis,2012

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary composition and its association with metabolic dysfunction-associated fatty liver disease among Chinese adults: A cross-sectional study;Arab Journal of Gastroenterology;2024-05

2. Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials;Drugs;2024-03-13

3. Evolution of characteristics of MASLD with and without diabetes: A meta- analysis of placebo arms;2024-01-30

4. Comparison of Efficacy between Pemafibrate and Omega-3-Acid Ethyl Ester in the Liver: the PORTRAIT Study;Journal of Atherosclerosis and Thrombosis;2024

5. Omega-3 fatty acids supplementation improves early-stage diabetic nephropathy and subclinical atherosclerosis in pediatric patients with type 1 diabetes: A randomized controlled trial;CLIN NUTR;2023